Kalytera Therapeutics Inc (KALY)

[onedayyyyyyyyy]

Already done ..now we have cash ..
SAN FRANCISCO and TEL AVIV, Israel, Jan. 15, 2019 (GLOBE NEWSWIRE) --

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the “Company” or “Kalytera”) is pleased to announced the closing of its previously announced private placement of 11,532,000 common shares of the Company and 11,532,000 common share purchase warrants for aggregate gross proceeds of C$605,430. Alere Financial Partners, a division of Cova Capital Partners LLC, acted as agent in the offering and as compensation will receive a cash commission equal to 8% of the aggregate gross proceeds and will be issued 922,560 warrants bearing the same terms as those issued in the offering. All securities issued in the offering are subject to a hold period expiring on May 16, 2019 in accordance with applicable securities laws. The offering remains subject to final TSX Venture Exchange approval.


Read more at http://www.stockhouse.com/companies/bullboard/v.kaly/kalytera-therapeutics-inc#0YXpxVmkc761hcRT.99